Your browser doesn't support javascript.
loading
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Golpanian, Samuel; DiFede, Darcy L; Pujol, Marietsy V; Lowery, Maureen H; Levis-Dusseau, Silvina; Goldstein, Bradley J; Schulman, Ivonne H; Longsomboon, Bangon; Wolf, Ariel; Khan, Aisha; Heldman, Alan W; Goldschmidt-Clermont, Pascal J; Hare, Joshua M.
Afiliação
  • Golpanian S; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
  • DiFede DL; Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Pujol MV; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Lowery MH; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Levis-Dusseau S; Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Goldstein BJ; Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Schulman IH; Division of Endocrinology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Longsomboon B; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Wolf A; Department of Otolaringology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Khan A; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Heldman AW; Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Goldschmidt-Clermont PJ; Division of Nephrology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Hare JM; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Oncotarget ; 7(11): 11899-912, 2016 Mar 15.
Article em En | MEDLINE | ID: mdl-26933813

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Envelhecimento / Doenças Cardiovasculares / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / Imunidade Inata / Inflamação Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Envelhecimento / Doenças Cardiovasculares / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / Imunidade Inata / Inflamação Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos